In a survey of 377 buprenorphine prescribers in Michigan, high-threshold practices such as requiring counseling as a condition for buprenorphine treatment and conducting drug testing during every in-office visit were associated with higher rates of treatment termination for patients receiving buprenorphine. Buprenorphine treatment continuity is critical to preventing overdose deaths amidst an intensifying national overdose crisis. State policy reforms encouraging practices to retain patients in treatment even if they do not strictly adhere to counseling recommendations and limiting drug testing to a clinically relevant frequency could improve overall patient engagement with buprenorphine treatment and save lives.
Published January 16, 2024
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Relatório de Atividades 2025 – Brasil
Mais Dados Mais Saúde – Percepções da população brasileira sobre fatores de risco…
What Primary Care Records Reveal About Cancer Signs and Symptoms
O que os prontuários da atenção primária revelam sobre sinais e sintomas de…
CRVS Performance Measurement and Monitoring Resource Kit
Model Kentucky Ordinance Establishing a County Opioid Abatement Advisory Council
The invisible pain: Gaps in Brazil’s public health system data on Menstrual and…
Exploring the Interface Between Birth Registration and Citizenship Determination: A Scoping Study in…
A dor invisível: lacunas nos dados do SUS sobre dor menstrual e pélvica
Catalyzing Support for CRVS Improvement – Examples from the Data for Health Initiative